Astria Therapeutics inc   (ATXS)

ATXS, contraction in the corporate conduct during the most recent fiscal period

company announced fourth quarter of 2022 operating shortfall of $-14.29 millions

Published Mar 23 2023
Goran Soko / CSIMarket.com Contributer

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons As the earnings season of the October to December 31 2022 goes on, many corporations have reported the earnings. In the thick of it, are many constituents of the Major Pharmaceutical Preparations industry. And today, ATXS reported operating deficit of $-14.29 millions, for the October to December 31 2022 span.

The operating deficit has worsened from $-9.507 millions, from the fourth quarter of 2021. But more importantly, the market observers are speculating, if the ATXSs' could begin to cite the revenue.

The company is seeking various corporate policies, in attempt to assure steady service. During the same period the shortfalls, which the Astria Therapeutics Inc has dealt with amid the expanding stage, have expanded to $-13.264 millions, from $-9.491 millions, relative to the same period a year ago.

Even more, the Astria Therapeutics Inc claimed as well net deficit of $-51.83 millions and for the fiscal year 2022, Revenues of $0.00 millions.

Major Pharmaceutical Preparations Astria Therapeutics Inc has decreased it's deficit per share to $-3.55 from $-24.58 in the previous fiscal year, while by 0 % from $0.00 millions a year before.

Astria Therapeutics Inc is expected to report next financial results on May 11, 2023.

Astria Therapeutics Inc's ROA

Astria Therapeutics Inc's ROA

Other ATXS's Earnings Reports

Other ATXS's Earnings Reports


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071